Trial Profile
A Retrospective study to evaluate the efficacy of Apremilast in patients with Chronic plaque psoriasis in Australia: A real world experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 May 2018 New trial record